Document is current
Any future updates will be listed below
-
Authors
Zavidij, Oksana
Haradhvala, Nicholas J. http://orcid.org/0000-0003-1113-3135
Mouhieddine, Tarek H. http://orcid.org/0000-0002-1190-5978
Sklavenitis-Pistofidis, Romanos
Cai, Songjie http://orcid.org/0000-0002-8166-4356
Reidy, Mairead
Rahmat, Mahshid http://orcid.org/0000-0001-7100-463X
Flaifel, Abdallah
Ferland, Benjamin
Su, Nang K.
Agius, Michael P. http://orcid.org/0000-0003-2356-4274
Park, Jihye
Manier, Salomon
Bustoros, Mark
Huynh, Daisy
Capelletti, Marzia
Berrios, Brianna
Liu, Chia-Jen http://orcid.org/0000-0001-7945-9292
He, Meng Xiao
Braggio, Esteban
Fonseca, Rafael
Maruvka, Yosef E.
Guerriero, Jennifer L.
Goldman, Melissa
Van Allen, Eliezer M. http://orcid.org/0000-0002-0201-4444
McCarroll, Steven A.
Azzi, Jamil
Getz, Gad http://orcid.org/0000-0002-0936-0753
Ghobrial, Irene M. http://orcid.org/0000-0001-7361-3092
- License Information
-
More Information
Article History
Received: 30 October 2019
Accepted: 10 March 2020
First Online: 27 April 2020
Competing interests
: G.G. receives research funds from IBM and Pharmacyclics and is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect and POLYSOLVER. I.M.G. has a consulting/advisory role with GSK, AbbVie and Bristol Myers Squibb. I.M.G has a consulting role with Sanofi, Janssen Pharmaceuticals, Takeda, Celgene, Karyopharm, GNS, Cellectar Biosciences, Medscape, Genetech, Adaptive Biotechnologies, Aptitude, Curio Science, Magenta Therapeutics and Oncopeptides. I.M.G. received research funding/ honoraria from Celgene, Takeda, Bristol Myers Squibb, Janssen Pharmaceuticals and Amgen.
